Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG.

Acta oncologica (Stockholm, Sweden) - 1 Jan 2018

Soenderstrup I M H, Laenkholm A V, Jensen M B, Eriksen J O, Gerdes A M, Hansen T V O, Kruse T A, Larsen M J, Pedersen I S, Rossing M, Thomassen M, Ejlertsen B

Abstract excerpt

BACKGROUND: In breast cancer (BC) patients a cancer predisposing BRCA1/2 mutation is associated with adverse tumor characteristics, risk assessment and treatment allocation. We aimed to estimate overall- (OS) and disease-free survival (DFS) according to tumor characteristics and treatment among women who within two years of definitive surgery for primary BC were shown to carry a mutation in BRCA1/2 . MATERIAL AND...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Denmark

Share to Disease-Free Survival

Share to Mastectomy

Share to Neoplasm Recurrence, Local

Share to Registries

Source

Identifiers

PMID: 29164974
DOI: 10.1080/0284186X.2017.1398415

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG.PMID 29164974Read ↗

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study.Semantic proximity Read ↗

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypesSemantic proximity Read ↗

Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.Semantic proximity Read ↗

BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis.Semantic proximity Read ↗

Does bilateral mastectomy affect clinical outcomes in BRCA1/2 mutation carriers with primary breast cancer? A systematic review and meta-analysis.Semantic proximity Read ↗

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review.Semantic proximity Read ↗

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.Semantic proximity Read ↗

Breast cancer treatment in mutation carriers: surgical treatment.Semantic proximity Read ↗

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities.Semantic proximity Read ↗

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.